February 5th, 2010
Podcast 73: How best to monitor patients on androgen-deprivation therapy for cardiovascular risks?
Podcast: Play in new window | Download
Subscribe: RSS
A panel of the American Heart Association, the American Cancer Society, and the American Urological Association issued a statement on androgen-deprivation therapy and cardiovascular risk. We’ve got an interview with the chair of the writing committee, Dr. Glenn Levine.
Interview-related links:
- Physician’s First Watch coverage of the statement
- Link to the statement, as published in Circulation
News-related links:
- Lancet retracts 1998 paper linking MMR vaccination and autism
- Use prefilled Sanofi Pasteur N1N1 vaccines before mid-February
- JAMA study on proteinuria
If you’d like to contact Clinical Conversations, call 1-617-440-4374 or write to jelia@jwatch.org
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Follow us:
